STAAR Surgical holds Q4/FY2023 earnings call; partial transcript provided, no specific results extractable.

STAAR SURGICAL CO

STAAR Surgical held earnings call on 2/26/2024 for Q4 and FY2023 results; transcript furnished as Exhibit 99.1.
Participants included CEO Tom Frinzi and CFO Patrick Williams.
Analyst participants from Morgan Stanley, Canaccord Genuity, William Blair, Stephens, BTIG, Mizuho, Piper Sandler, Needham, Oppenheimer, Stifel, Sidoti.
Specific financial figures (EPS, revenue, guidance) are absent from the provided text; only call introduction is present.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.